The first deliveries of lenacapavir to the African continent represent a turning point in the fight against HIV.

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

An uncounted number of extra people have died from AIDS and 2.5 million have lost access to medicine to block the spread of ...

The global fight to prevent new HIV cases by 2030 is facing its most significant setback in decades, according to the UN’s latest annual report. Experts warned the sudden funding cuts to international ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre-exposure ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...